Post-Licensure Safety Surveillance Study of Routine Use of PENTACEL Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine.

Trial Profile

Post-Licensure Safety Surveillance Study of Routine Use of PENTACEL Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Aug 2015

At a glance

  • Drugs Hib-DTaP-poliovirus vaccine (Primary) ; DTaP vaccine
  • Indications Diphtheria; Haemophilus infections; Pertussis; Poliomyelitis; Tetanus
  • Focus Adverse reactions
  • Sponsors Sanofi
  • Most Recent Events

    • 18 Aug 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
    • 25 Mar 2015 Planned End Date changed from 1 Jan 2015 to 1 May 2015 as per ClinicalTrials.gov record.
    • 24 Apr 2013 Planned End Date changed from 1 Dec 2013 to 1 Jan 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top